|
ZNF124 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.2289004803232E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.47700000405504E-08 |
| Normal-vs-Stage2 |
1.10490000038155E-07 |
| Normal-vs-Stage3 |
2.97429999518428E-08 |
| Normal-vs-Stage4 |
4.47140000026103E-07 |
| Stage1-vs-Stage2 |
1.969040E-01 |
| Stage1-vs-Stage3 |
2.978800E-01 |
| Stage1-vs-Stage4 |
2.017600E-01 |
| Stage2-vs-Stage3 |
6.304000E-01 |
| Stage2-vs-Stage4 |
9.898600E-01 |
| Stage3-vs-Stage4 |
6.511800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.49020004616796E-09 |
| Normal-vs-AfricanAmerican |
1.855390E-03 |
| Normal-vs-Asian |
8.775300E-04 |
| Caucasian-vs-AfricanAmerican |
5.816600E-01 |
| Caucasian-vs-Asian |
1.706610E-01 |
| AfricanAmerican-vs-Asian |
6.705400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.77650000160656E-09 |
| Normal-vs-Female |
3.01820002324149E-09 |
| Male-vs-Female |
3.553600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.2037999997403E-07 |
| Normal-vs-Age(41-60Yrs) |
5.09840003548589E-09 |
| Normal-vs-Age(61-80Yrs) |
1.37229999586097E-08 |
| Normal-vs-Age(81-100Yrs) |
5.763600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.827610E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.729190E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.421600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.382600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.726200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.268200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.685160E-01 |
| Classical-VS-Follicular |
1.838390E-04 |
| Classical-VS-Other |
2.126200E-01 |
| Classical-VS-Normal |
4.01230000002251E-07 |
| Tall-VS-Follicular |
3.015600E-01 |
| Tall-VS-Other |
5.695000E-01 |
| Tall-VS-Normal |
1.70163999999584E-05 |
| Follicular-VS-Other |
9.797600E-01 |
| Follicular-VS-Normal |
2.25860441460668E-11 |
| Other-VS-Normal |
4.536800E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.83710002765736E-09 |
| Normal-vs-N1 |
3.7838999999984E-07 |
| N0-vs-N1 |
7.835200E-01 |
|
|
